To stimulate innovation and entrepreneurship in both education and research IXA has, in collaboration with the City of Amsterdam, developed the valorisation program IXAnext; Talent for Innovation. All Amsterdam universities and knowledge institutes are involved: HvA, UvA, VU, Amsterdam UMC and the NWO institutes AMOLF and NIKHEF. In a five year periode, 2017-2021, they collaborate in utilizing and disseminate knowledge and stimulate economic activity and entrepreneurship. All for the greater good and benefit of Amsterdams research and entrepreneurial ecosystem.
Benefits for researchers, teachers, students, entrepreneurs, companies… for who not?
The program offers facilities and funding, infrastructure, educational measures, a network and much more. Researchers, teachers and students have the incubators Amsterdam Venture Studios and Demonstrator Lab at their disposal to develop and test their business cases or accommodate their start-up activities.
Companies and non profits can benefit from the latest scientific expertise and research facilities with the Physics on Demand service. The Research Facilities database helps R&D departments to find specialized, high end equipment and instruments.
Teachers in Entrepreneurship can find inspiration for their education program and lessons with the Entrepreneurship cases and the pilot Blended Learning.
Students with plans for a start-up can profit from the knowledge of mentors found through the platform Startup and Running.
It is save to state IXAnext offers something for everyone.
Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties. BOM Brabant Ventures en GAP Technologies investeren in het bedrijf voor de verdere ontwikkeling van de apparatuur en de disposables. Haermonics blijft samenwerken met Amsterdam […]News
This collaboration is part of 2-year UK government-funded project to bring RxSelexTM closer to patients Amsterdam UMC and AlphaBiomics Ltd., a United Kingdom (UK)-based precision medicine company, have initiated a collaboration to personalize care in patients suffering from inflammatory bowel disease (IBD). IBD patient response to biologics therapy is highly variable, with some patients receiving long-term benefits, […]News
Fitsurance and how they ‘pivot’ during COVID-19, as a VU ‘personal health’ startup All was lost (well, almost) After a great pilot-project in Zeeland, where we measured runners on the beach, to see what a 3-day running event did with runners’ health, we stepped up our efforts to prepare for 2020, in order to make […]News